22 Fanconi Anemia Clinical Trials in Kansas City, MO (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Fanconi Anemia Studies in Kansas City

NCT07112924Recruiting

CCM OPEN HF Registry

The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting....

Kansas City, MO5,500 participantsImpulse Dynamics

View Study Details

NCT07232030Recruiting

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

The purpose of BENEFIT-HF is to demonstrate the safety and effectiveness of Baroreflex Activation Therapy (BAT) with the Barostim System in participants with heart failure, defined as NYHA Functional ...

Kansas City, MONA2,500 participantsCVRx, Inc.

View Study Details

NCT06425848Recruiting

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmo...

Kansas City, MO2,000 participantsUniversity of Kansas Medical Center

View Study Details

NCT05934487Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure...

Kansas City, MONA1,750 participantsEndotronix, Inc.

View Study Details

NCT07574593Recruiting

NORM-HF Pivotal Study

This is an international, multi-center, prospective, randomized, open-label blinded endpoint study designed to demonstrate that use of the FIRE1 NORM™ System in the management of New York Heart Associ...

Kansas City, MONA800 participantsFoundry Innovation & Research 1, Limited (FIRE1)

View Study Details

NCT06678841Recruiting

ELEVATE-HFpEF Clinical Study

ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compar...

Kansas City, MONA700 participantsMedtronic Cardiac Rhythm and Heart Failure

View Study Details

NCT01893710Recruiting

International (Pediatric) Peritoneal Biobank

Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients undergoes substantial morphological transformation, including progressive fibrosis, vasculopathy and neoangiogenesis...

Kansas City, MO500 participantsHeidelberg University

View Study Details

NCT05446272Recruiting

The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial

DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 23 0/7-28 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasi...

Kansas City, MONA478 participantsUniversity of Pennsylvania

View Study Details

NCT06898515Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute dec...

Kansas City, MONA400 participantsReprieve Cardiovascular, Inc

View Study Details

NCT07098858Recruiting

The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)

Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System...

Kansas City, MO320 participantsEBR Systems, Inc.

View Study Details

NCT07038200Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...

Kansas City, MOPHASE3200 participantsAvidity Biosciences, Inc.

View Study Details

NCT06950385Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compa...

Kansas City, MOPHASE3168 participantsRapamycin Holdings Inc.

View Study Details

NCT06917911Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

This phase II MYELOMATCH treatment trial compares the effect of venetoclax to gemtuzumab ozogamicin, when given with cytarabine and daunorubicin ("7+3" regimen), for the treatment of patients with cor...

Kansas City, MOPHASE2162 participantsNational Cancer Institute (NCI)

View Study Details

NCT07192952Recruiting

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Researchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left ventricular systolic dysfu...

Kansas City, MOPHASE3117 participantsBayer

View Study Details

NCT07188805Recruiting

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Researchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where the heart is unable to p...

Kansas City, MOPHASE3111 participantsBayer

View Study Details

NCT03523416Recruiting

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards APTURE transcatheter shunt system....

Kansas City, MONA90 participantsEdwards Lifesciences

View Study Details

NCT06847282Recruiting

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

The primary goal of this study is to validate motor and functional outcomes and refine clinical trial strategies for pediatric-onset FSHD...

Kansas City, MO80 participantsUniversity of Kansas Medical Center

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

Kansas City, MOPHASE380 participantsBoehringer Ingelheim

View Study Details

NCT04270045Recruiting

Forced Oscillometry in Infants With Bronchopulmonary Dysplasia

The purpose of this study is to use forced oscillometry technique (FOT) to measure pulmonary mechanics and function in in term infants and premature infants with bronchopulmonary dysplasia (BPD)...

Kansas City, MO80 participantsWinston Manimtim

View Study Details

NCT06721299Recruiting

Clenbuterol to Target DUX4 in FSHD

The purpose of this study is to determine if Clenbuterol is a therapeutic option for FSHD by determining the safety and tolerability of the medication at three different dose levels....

Kansas City, MOPHASE130 participantsJeffrey Statland

View Study Details

NCT06018064Recruiting

Investigating Fit and Satisfaction of the Prone Positioner

The goal of this clinical trial is to learn about the use of the Prone Positioner in pediatric patients with tracheostomies (trachs). The main question\[s\] it aims to answer are: * What is the fit a...

Kansas City, MONA30 participantsChildren's Mercy Hospital Kansas City

View Study Details

NCT06858397Recruiting

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD....

Kansas City, MOPHASE118 participantsGC Biopharma Corp

View Study Details

About Fanconi Anemia Clinical Trials in Kansas City

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 22 fanconi anemia clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 16,114 participants. Research is being sponsored by Impulse Dynamics, CVRx, Inc., University of Kansas Medical Center and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Kansas City — FAQ

Are there fanconi anemia clinical trials in Kansas City?

Yes, there are 22 fanconi anemia clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 22 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated October 19, 2026 from ClinicalTrials.gov